(+)-6-methyl-1-indanol | 200425-65-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: (+)-6-methyl-1-indanol
• 英文别名: (+)-(S)-6-Methyl-1-indalol；(1S)-6-methyl-2,3-dihydro-1H-inden-1-ol
• CAS: 200425-65-6
• 化学式: C₁₀H₁₂O
• 分子量: 148.205
• InChiKey: ATIMDIDJGWMTDD-JTQLQIEISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  6-甲基-1-茚酮 在 N,N-diethylaniline borane 、 硼酸三甲酯 、 chiral 2-(diphenylhydroxymethyl)pyrrolidine 作用下， 以 甲苯 为溶剂， 生成 (+)-6-methyl-1-indanol
  参考文献：
  名称：

  Stereochemical Sensitivity of the Human UDP-glucuronosyltransferases 2B7 and 2B17

  摘要：

  A set of 28 enantiomers comprising rigid and flexible secondary alcohols was synthesized by the asymmetric Corey-Bakshi-Shibata reduction. The enantiomerically pure alcohols were subjected to enzymatic glucuronidation assays employing the human UDP-glucuronosyltransferases (UGTs) 2B7 and 2BI7. Both UGTs displayed high levels of stereo selectivity, favoring the conjugation of the (R)-enantiomers over their respective (S)-stereoisomers at eudismic ratios up to 256. The spatial arrangement of the hydroxy group determined the diastereoselectivity of the UGT2B17-catalyzed reaction in agreement with Pfeiffer's rule (eudismic activity quotient = 0.83 +/- 0.14). Inhibition studies revealed that the enantiomers had similar affinities toward the enzymes. The diastereoselectivity of the UGT-catalyzed conjugation stemmed, therefore, from the arrangement of the substrates in the catalytic site, rather than from distinct affinities toward the enzymes. Taken together, this study showed that metabolic enzymes that are generally conceived to be rather "flexible" in nature are capable of displaying high levels of chiral distinction.

  DOI：

  10.1021/jm051142c

文献信息

• Oxidative Kinetic Resolution of Racemic Alcohols Catalyzed by Chiral Ferrocenyloxazolinylphosphine−Ruthenium Complexes
  作者：Yoshiaki Nishibayashi、Akiyoshi Yamauchi、Gen Onodera、Sakae Uemura

  DOI：10.1021/jo0345087

  日期：2003.7.1

  Oxidative kinetic resolution of racemic secondary alcohols by using acetone as a hydrogen acceptor in the presence of a catalytic amount of [RuCl(2)(PPh(3))(ferrocenyloxazolinylphosphine)] (2) proceeds effectively to recover the corresponding alcohols in high yields with an excellent enantioselectivity. When 1-indanol is employed as a racemic alcohol, the oxidation proceeds quite smoothly even in the

  在催化量的[RuCl（2）（PPh（3））（二茂铁基恶唑啉基膦）]（2）的存在下，通过使用丙酮作为氢受体，消旋外消旋仲醇的氧化动力学拆分有效地进行，以高收率回收了相应的醇具有出色的对映选择性。当将1-茚满醇用作外消旋醇时，即使在0.0025 mol％的催化剂2的存在下，氧化也能非常平稳地进行，从而以高收率和高对映选择性（最高94％ee）得到光学活性的1-茚满醇，周转频率（TOF）超过80,000 h（-1）。从实践的角度出发，大规模研究了动力学拆分，通过使用消旋的1-茚满醇（134 g）获得了光学纯的（S）-1-茚满醇（75 g，56％收率，> 99％ee）。此动力学拆分方法两次。
• Access to valuable building blocks by the regio- and enantioselective ring opening of itaconic anhydride by lipase catalysis
  作者：Nabila Braïa、Mounia Merabet-Khelassi、Martial Toffano、Regis Guillot、Louisa Aribi-Zouioueche

  DOI：10.1039/d2ob00047d

  日期：——

  first time the highly regio- and enantioselective ring opening of a biobased itaconic anhydride catalyzed by the Pseudomonas cepacia lipase (PCL) in tert-butyl methyl ether (TBME) at room temperature. This method is easy, efficient and eco-friendly and can be performed in one step with a series of highly valuable monoester itaconates (achiral or enantioenriched) using various alcohols as nucleophiles

  在此，我们首次报道了由洋葱假单胞菌脂肪酶 ( PCL )催化的生物基衣康酸酐的高度区域和对映选择性开环。-丁基甲基醚 (TBME) 在室温下。该方法简单、高效、环保，可以一步完成一系列高价值的衣康酸单酯（非手性或对映体富集），使用各种醇作为亲核试剂，原子经济性为 100%。在所有情况下，β-单酯异构体都是反应的主要产物。使用非手性伯醇作为底物，以中等至优异的产率（50-90%）获得了多种新型衣康酸酯。对于选定的示例，除了标准技术外，还使用 ​​X 射线衍射进行了产品表征。该方法的应用是通过酶动力学拆分制备对映体富集的 4-单酯衣康酸酯。
• HYDROXY-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US20160068510A1

  公开（公告）日：2016-03-10

  The present invention is directed to hydroxy compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及一种与荷尔蒙受体对抗的羟基化合物。本发明还涉及使用此处所述的化合物在潜在的神经和精神障碍和疾病的治疗或预防中所用。本发明还涉及包含这些化合物的药物组合物。本发明还涉及这些药物组合物在预防或治疗与荷尔蒙受体有关的这些疾病中的使用。
• US9725434B2
  申请人：——

  公开号：US9725434B2

  公开（公告）日：2017-08-08
• Stereochemical Sensitivity of the Human UDP-glucuronosyltransferases 2B7 and 2B17
  作者：Ingo Bichlmaier、Antti Siiskonen、Moshe Finel、Jari Yli-Kauhaluoma

  DOI：10.1021/jm051142c

  日期：2006.3.1

  A set of 28 enantiomers comprising rigid and flexible secondary alcohols was synthesized by the asymmetric Corey-Bakshi-Shibata reduction. The enantiomerically pure alcohols were subjected to enzymatic glucuronidation assays employing the human UDP-glucuronosyltransferases (UGTs) 2B7 and 2BI7. Both UGTs displayed high levels of stereo selectivity, favoring the conjugation of the (R)-enantiomers over their respective (S)-stereoisomers at eudismic ratios up to 256. The spatial arrangement of the hydroxy group determined the diastereoselectivity of the UGT2B17-catalyzed reaction in agreement with Pfeiffer's rule (eudismic activity quotient = 0.83 +/- 0.14). Inhibition studies revealed that the enantiomers had similar affinities toward the enzymes. The diastereoselectivity of the UGT-catalyzed conjugation stemmed, therefore, from the arrangement of the substrates in the catalytic site, rather than from distinct affinities toward the enzymes. Taken together, this study showed that metabolic enzymes that are generally conceived to be rather "flexible" in nature are capable of displaying high levels of chiral distinction.